Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BRAXF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.21
N/A
-0.01
vs -0.01
Q4.21
N/A
-0.01
vs -0.01
Q1.22
N/A
-0.03
vs -0.01
Q2.22
N/A
-0.00
vs -0.01
Q3.22
N/A
-0.01
vs -0.01
Q4.22
N/A
-0.01
vs -0.01
Q1.23
N/A
-0.02
vs -0.03
Q2.23
N/A
-0.00
vs -0.00
Q3.23
N/A
-0.00
vs -0.01
Q4.23
N/A
-0.00
vs -0.01
Sales Growth
YoY
Current
Estimates
Q1.22
+50%
369.7K vs 246.7K
Q2.22
+3%
417.5K vs 407.1K
Q3.22
+18%
455.3K vs 385.5K
Q4.22
+51%
489K vs 324.9K
Q1.23
+41%
522.4K vs 369.7K
Q2.23
+44%
600.2K vs 417.5K
Q3.23
+30%
594.1K vs 455.3K
Q4.23
+1%
492.4K vs 489K
Q1.24
+40%
730.6K vs 522.4K
Q2.24
+39%
835K vs 600.2K
Return on Equity
QoQ
Q1.22
-76%
-0.76
vs -0.20
Q2.22
-12%
-0.12
vs -0.76
Q3.22
-22%
-0.22
vs -0.12
Q4.22
-27%
-0.27
vs -0.22
Q1.23
-477%
-4.77
vs -0.27
Q2.23
-100%
-1.00
vs -4.77
Q3.23
-51%
-0.51
vs -1.00
Q4.23
+248%
2.48
vs -0.51
Institutionnal Ownership
QoQ
Q4.22
2
2
vs 3
-33%
Q1.23
1
1
vs 2
-50%
Q2.23
2
2
vs 1
100%
Q3.23
2
2
vs 2
NA
Q4.23
1
1
vs 2
-50%
Q1.24
1
1
vs 1
NA
Q2.24
1
1
vs 1
NA
Q3.24
1
1
vs 1
NA
newsfilecorp.com
7 hours ago
newsfilecorp.com
17 hours ago
newsfilecorp.com
17 hours ago
newsfilecorp.com
18 hours ago
newsfilecorp.com
18 hours ago
newsfilecorp.com
18 hours ago
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.
PNK
Unprofitable
Unprofitable
0.00Â ( 16.67%)
Relative Strenght
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
80%Relative Strength
BRAXF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
504%2024-Revenue
-268%2024-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics